Patents by Inventor Young Woo Jin

Young Woo Jin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11915832
    Abstract: A method for processing data for discovering a new drug candidate substance by a data processing apparatus includes receiving at least some of omics levels that make up omics through a user interface, receiving at least some types of mutual association degrees among a plurality of types of mutual association degrees, selecting a DB for the at least some of the omics levels and a DB for the at least some types of mutual association from an omics DB including data for each omics level and data for each type of mutual association, generating a first matrix composed of the DB for the at least some of the omics levels and the DB for the at least some types of mutual association degrees, receiving a predetermined search word through the user interface, extracting a plurality of biological entities, and generating a multi-omics network in which a plurality of nodes.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: February 27, 2024
    Assignee: MEDIRITA
    Inventors: Young Woo Pae, Seung-Hyun Jin
  • Patent number: 10646528
    Abstract: The present invention relates to a method for increasing the content of rare ginsenosides in preparing an extract of genus Panax including wild ginseng or ginseng, cambial meristematic cells of genus Panax or an extract thereof, a ginseng extract prepared by the method, cambial meristematic cells (CMCs) of genus Panax or an extract thereof prepared by the method, and to a composition comprising the same.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: May 12, 2020
    Assignee: WELLKEY HOLDINGS LIMITED
    Inventors: Young-Woo Jin, Eun-Kyong Lee, Young Mi Lee, Il Seok Oh
  • Patent number: 10087452
    Abstract: Plant cells express a target protein, a production method thereof, and a method of producing a target protein using the same are disclosed. The plant cells have introduced therein a recombinant vector containing gene(s) encoding a target protein, and the plant cells include plant cambial meristematic cells (CMC) or callus. The cambial meristematic cells (CMCs) are a cell line containing innately undifferentiated cells isolated from a plant, wherein the cell line is a cell line isolated from the cambial tissue of the plant and has meristematic continuity without going through dedifferentiation into callus. A system of expressing a target protein using the recombinant plant cells according to the present invention can overcome the problems of conventional plant cell culture. In addition, it shows significantly high transformation efficiency, and thus can produce large amounts of target proteins, including biopharmaceutical proteins.
    Type: Grant
    Filed: February 28, 2014
    Date of Patent: October 2, 2018
    Assignee: WELLKEY HOLDINGS LIMITED
    Inventors: Young Woo Jin, Eun Kyong Lee, Mi Ok Jang, Bora Park, Soo Ran Lee, Bo Rim Yang, Il Suk Kim, Il Seok Oh
  • Publication number: 20170232049
    Abstract: The present invention relates to a method for increasing the content of rare ginsenosides in preparing an extract of genus Panax including wild ginseng or ginseng, cambial meristematic cells of genus Panax or an extract thereof, a ginseng extract prepared by the method, cambial meristematic cells (CMCs) of genus Panax or an extract thereof prepared by the method, and to a composition comprising the same.
    Type: Application
    Filed: August 24, 2015
    Publication date: August 17, 2017
    Inventors: Young-Woo Jin, Eun-Kyong Lee, Young Mi Lee, Il Seok Oh
  • Patent number: 9633638
    Abstract: An apparatus is provided for simulating a musical instrument, comprising: a display configured to present a musical interface associated with an external image; a musical instrument setter configured to associate the musical interface with the musical instrument; and a sound area controller configured to arrange a portion of the musical interface as a sound area.
    Type: Grant
    Filed: August 5, 2015
    Date of Patent: April 25, 2017
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Chung-Ryeol Lim, Sang-Kyu Park, Young-Woo Jin
  • Patent number: 9585923
    Abstract: The present invention relates to an antioxidant, anti-inflammatory or anti-aging composition containing any one or more of a Taxus cambium- or procambium-derived cell line, an extract thereof, a lysate thereof and a culture medium thereof. The composition according to the present invention has minimized side effects compared to existing antioxidants and anti-inflammatory agents, is involved in intracellular metabolism to reduce intracellular reactive oxygen species, and reduces and induces aging-related signals. Thus, the composition of the preset invention is useful for preventing and delaying aging. In addition, the composition of the present invention has the effect of inhibiting melanogenesis, and thus is useful as a whitening cosmetic composition.
    Type: Grant
    Filed: May 14, 2009
    Date of Patent: March 7, 2017
    Assignee: UNHWA CORPORATION
    Inventors: Dae Hee Lee, Eun Kyong Lee, Eun Mi So, Young Woo Jin
  • Patent number: 9415081
    Abstract: The present invention relates to a composition for preventing or treating acquired immunodeficiency syndrome (AIDS), comprising one or more of the following: a homogenous cell line, and a lysate, an extract and a culture thereof as an active ingredient. The homogenous cell line, the lysate, the extract and the culture thereof, which are derived from a natural product, minimize adverse side effects of prior therapeutic agents and safe for the human body. Further, they effectively increase the count of T cells such as CD4+ T cells and decrease the number of HIVs, thereby preventing opportunistic infection, dysneuria, and neoplaia caused by immune incompetence, and ultimately the risk of death. Therefore, they are useful in preventing and treating AIDS, and relieving symptoms of AIDS.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: August 16, 2016
    Assignees: UNHWA CORPORATION
    Inventors: Sun Mi Hong, Eun Kyong Lee, Young Woo Jin
  • Patent number: 9314492
    Abstract: The present invention relates to a composition for preventing or treating cancer, which contains, as an active ingredient, a Panax ginseng cambium-derived cell line including wild ginseng or ginseng; a lysate thereof; an extract thereof; or a culture medium thereof, which are derived from a natural and have minimized side effects compared to the conventional therapeutic drugs, and thus are safe for the human body. Also, they are involved directly in the growth of cancer to induce cancer cell death effectively, and show anticancer activity of inhibiting or reducing the formation of tumor or the growth of tumor.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: April 19, 2016
    Assignees: UNHWA CORPORATION
    Inventors: Young Woo Jin, Eun Kyong Lee
  • Patent number: 9289457
    Abstract: The present invention relates to a composition for preventing or treating liver diseases, which contains, as an active ingredient, any one or more of a homogeneous cell line derived from the cambium of Panax ginseng, including wild ginseng or ginseng, a lysate thereof, an extract thereof and a culture medium thereof. The homogeneous cell line according to the present invention, a lysate thereof, an extract thereof and a culture medium thereof have minimized side effects compared to existing agents for treating liver diseases, and thus are safe for the human body. Also, they can increase the levels of s-antibody (HBsAb) and e-antibody (HBeAb) against hepatitis virus and inhibit the proliferation of hepatitis virus, and thus they are useful for the prevention and treatment of liver diseases. In addition, they have the effect of lowering the levels of liver injury, and thus are useful as a functional food for improving liver function.
    Type: Grant
    Filed: April 16, 2013
    Date of Patent: March 22, 2016
    Assignees: UNHWA COPRORATION
    Inventors: Young Woo Jin, Eun Kyong Lee, Min Jung Lim
  • Publication number: 20160042727
    Abstract: An apparatus is provided for simulating a musical instrument, comprising: a display configured to present a musical interface associated with an external image; a musical instrument setter configured to associate the musical interface with the musical instrument; and a sound area controller configured to arrange a portion of the musical interface as a sound area.
    Type: Application
    Filed: August 5, 2015
    Publication date: February 11, 2016
    Inventors: Chung-Ryeol LIM, Sang-Kyu PARK, Young-Woo JIN
  • Publication number: 20160010099
    Abstract: Plant cells express a target protein, a production method thereof, and a method of producing a target protein using the same are disclosed. The plant cells have introduced therein a recombinant vector containing gene(s) encoding a target protein, and the plant cells include plant cambial meristematic cells (CMC) or callus. The cambial meristematic cells (CMCs) are a cell line containing innately undifferentiated cells isolated from a plant, wherein the cell line is a cell line isolated from the cambial tissue of the plant and has meristematic continuity without going through dedifferentiation into callus. A system of expressing a target protein using the recombinant plant cells according to the present invention can overcome the problems of conventional plant cell culture. In addition, it shows significantly high transformation efficiency, and thus can produce large amounts of target proteins, including biopharmaceutical proteins.
    Type: Application
    Filed: February 28, 2014
    Publication date: January 14, 2016
    Inventors: Young Woo JIN, Eun Kyong LEE, Mi Ok JANG, Bora PARK, Soo Ran LEE, Bo Rim YANG, Il Suk KIM, Il Seok OH
  • Patent number: 9095532
    Abstract: The present invention relates to an anti-aging or antioxidant composition which contains, as an active ingredient, a plant stem cell line derived from the cambium of Panax ginseng, including wild ginseng and ginseng, or an extract thereof, a lysate thereof and a culture thereof. The composition has minimized side effects compared to existing anti-aging agents and antioxidants, and thus is safe for the skin. Also, the composition of the present invention shows an antioxidant effect of inhibiting reactive oxygen species caused by exposure to UV radiation that is the major cause of skin aging, and it can effectively reduce or inhibit aging-related factors. Thus, the composition is useful for the prevention and inhibition of aging.
    Type: Grant
    Filed: April 16, 2013
    Date of Patent: August 4, 2015
    Assignees: Unhwa Corporation
    Inventors: Mi Ok Jang, Min Jung Lim, Il Seok Oh, Dae Hee Lee, Eun Kyong Lee, Young Woo Jin
  • Patent number: 8790927
    Abstract: The present invention relates to a composition for preventing or treating cancer, which contains, as an active ingredient, a Taxus cambium- or procambium-derived cell line; a lysate thereof; an extract thereof; or a culture medium thereof. The cell line, the lysate, the extract, and the culture medium has minimized side effects compared to the conventional therapeutic drugs, is safe to the human body, is involved directly in the growth of cancer to induce cancer cell death, and shows anticancer activity of inhibiting angiogenesis occurring in carcinogenesis. Accordingly, the cell line, the lysate, the extract and the culture medium is useful for the prevention, treatment and alleviation of cancer.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: July 29, 2014
    Assignee: Unhwa Corporation
    Inventors: Joong Hyun Park, Min Jung Lim, Il Seok Oh, Dae Hee Lee, Jung Chang Lee, Eun Kyong Lee, Young Woo Jin
  • Patent number: 8617621
    Abstract: The present invention relates to a composition for enhancing immunity, comprising one or more of the following: a homogenous cell line, and a lysate, an extract and a culture medium thereof as an active ingredient. The homogenous cell line, the lysate, the extract and the culture thereof according to the present invention, which are derived from a natural product, minimize adverse side effects of prior immune enhancing agents and safe for the human body. Further, they effectively increase the activity of NK cells responsible for innate immunity, as well as increase the proliferation rate of lymph node cells when the cells were re-exposed to an antigen in a specific immune reaction to enhance acquired immunity, and thus are useful as an immune enhancing agent.
    Type: Grant
    Filed: February 23, 2010
    Date of Patent: December 31, 2013
    Assignees: Unhwa Corporation
    Inventors: Min Jung Lim, Young Woo Jin, Eun Kyong Lee
  • Publication number: 20130302287
    Abstract: The present invention relates to an anti-aging or antioxidant composition which contains, as an active ingredient, a plant stem cell line derived from the cambium of Panax ginseng, including wild ginseng and ginseng, or an extract thereof, a lysate thereof and a culture thereof. The composition has minimized side effects compared to existing anti-aging agents and antioxidants, and thus is safe for the skin. Also, the composition of the present invention shows an antioxidant effect of inhibiting reactive oxygen species caused by exposure to UV radiation that is the major cause of skin aging, and it can effectively reduce or inhibit aging-related factors. Thus, the composition is useful for the prevention and inhibition of aging.
    Type: Application
    Filed: April 16, 2013
    Publication date: November 14, 2013
    Inventors: Mi Ok Jang, Min Jung Lim, Il Seok Oh, Dae Hee Lee, Eun Kyong Lee, Young Woo Jin
  • Publication number: 20130137178
    Abstract: The present invention relates to a cell line derived from the cambium of an herbaceous plant having a storage root and a method for isolating the same. More specifically, relates to a cambium-derived homogeneous cell line having the ability to divide, which is obtained from the cambium-containing storage tissue of an herbaceous plant having a storage root without a separate dedifferentiation process, and to a method for isolating the same. The cell line derived from the cambium of an herbaceous plant having a storage root has an active division ability and is homogeneous. Also, it is stable during culture, because it has not undergone a dedifferentiation process. Thus, through the optimization of proliferation thereof, the cell line can be allowed to proliferate in a large amount within a short time.
    Type: Application
    Filed: July 17, 2012
    Publication date: May 30, 2013
    Applicant: Unhwa Corporation
    Inventors: Mi Ok Jang, Eun Kyong Lee, Young Woo Jin
  • Patent number: 8329471
    Abstract: This invention is a method of minimizing the variation of cell growth and production through homogeneous cell line development. To be more specific, it is the method of isolating and proliferating single cell clone from cambium or procambium to promote the stability of the plant-derived biologically active substances production by solving the problems of decrease in cell growth and the productivity during the long term culture.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: December 11, 2012
    Assignee: Unhwa Corporation
    Inventors: Young Woo Jin, Eun Kyong Lee
  • Patent number: 8247230
    Abstract: The present invention relates to a cell line derived from the cambium of an herbaceous plant having a storage root and a method for isolating the same. More specifically, relates to a cambium-derived homogeneous cell line having the ability to divide, which is obtained from the cambium-containing storage tissue of an herbaceous plant having a storage root without a separate dedifferentiation process, and to a method for isolating the same. The cell line derived from the cambium of an herbaceous plant having a storage root has active division ability and is homogeneous. Also, it is stable during culture, because it has not undergone a dedifferentiation process. Thus, through the optimization of proliferation thereof, the cell line can be allowed to proliferate in a large amount within a short time.
    Type: Grant
    Filed: September 22, 2008
    Date of Patent: August 21, 2012
    Assignee: Unhwa Corporation
    Inventors: Mi Ok Jang, Eun Kyong Lee, Young Woo Jin
  • Publication number: 20120189660
    Abstract: The present invention relates to a composition for preventing or treating liver diseases, which contains, as an active ingredient, any one or more of a homogeneous cell line derived from the cambium of Panax ginseng, including wild ginseng or ginseng, a lysate thereof, an extract thereof and a culture medium thereof. The homogeneous cell line according to the present invention, a lysate thereof, an extract thereof and a culture medium thereof have minimized side effects compared to existing agents for treating liver diseases, and thus are safe for the human body. Also, they can increase the levels of s-antibody (HBsAb) and e-antibody (HBeAb) against hepatitis virus and inhibit the proliferation of hepatitis virus, and thus they are useful for the prevention and treatment of liver diseases. In addition, they have the effect of lowering the levels of liver injury, and thus are useful as a functional food for improving liver function.
    Type: Application
    Filed: August 14, 2009
    Publication date: July 26, 2012
    Inventors: Young Woo Jin, Eun Kyong Lee, Min Jung Lim
  • Publication number: 20120039918
    Abstract: The present invention relates to a composition for enhancing immunity, comprising one or more of the following: a homogenous cell line, and a lysate, an extract and a culture medium thereof as an active ingredient. The homogenous cell line, the lysate, the extract and the culture thereof according to the present invention, which are derived from a natural product, minimize adverse side effects of prior immune enhancing agents and safe for the human body. Further, they effectively increase the activity of NK cells responsible for innate immunity, as well as increase the proliferation rate of lymph node cells when the cells were re-exposed to an antigen in a specific immune reaction to enhance acquired immunity, and thus are useful as an immune enhancing agent.
    Type: Application
    Filed: February 23, 2010
    Publication date: February 16, 2012
    Applicant: Unhwa Corporation
    Inventors: Min Jung Lim, Young Woo Jin, Eun Kyong Lee